Properties
Description
Pyrotinib is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR and HER2.
Molecular Formula
C32H31ClN6O3
Targets
EGFR: 13 nM; HER2: 38 nM
Identity
Confirmed by NMR/HPLC/MS.
Applications
EGFR-HER2 inhibitor Pyrotinib is used in research focused on its ability to inhibit EGFR and HER2, offering potential avenues for breast cancer treatment studies.